If you are one of the attendees that hasn't yet booked your room at the Boston Park Plaza for CMCH's 17th Annual Congress, please reserve your accommodations NOW before the block rate expires! BOOK YOUR STAY at the Plaza now, and, if you haven't registered for the conference yet, REGISTER today and mark your calendar for October 19-22, 2022, when the best and brightest in cardiometabolic medicine will assemble in Downtown Boston for The Present and Future of Cardiometabolic Health: Advances and Expert Perspectives. Topics covered by CMHC's illustrious roster of industry leaders at this year's Congress will include:

• Cardiometabolic health strategies in older adults
• Reversing the course of preobesity to prevent later obesity
• The role of imaging modalities in atherosclerosis and cardiovascular risk stratification
• Emerging data, guidelines, and practice pearls in type 2 diabetes
• Individualized therapy in heart failure management
• Cardiorenal risk reduction
• And many more!

We know the importance of cardiometabolic health, which patients are at risk, and how providers benefit from our education. But, the siloed model of care most physicians inherit when they begin practice doesn't include our comprehensive, multidisciplinary vision. Join us in sharing the impact and importance of the integrated cardiometabolic medicine industry with our new I am Cardiometabolic Medicine campaign. Read a compilation of provider stories from those who sought CMHC's educational initiatives because, as you'll read, they were tired, frustrated, and nearing the end of their already-limited resources. Hear how providers from multiple medical disciplines decided to shed the restrictions of their specialty and embrace CMHC's whole-patient concept of cardiometabolic care. Then, share your story to raise awareness and bring new practitioners into the cardiometabolic medicine family.

At CMHC, we know that the research data, clinical evidence, and practical strategies presented in our cardiometabolic education have one ultimate didactic purpose: to be applied in your practice with the goal of improving and lengthening your patients' lives. With that in mind, each month, we want to bring you a patient case that has been presented by one of our faculty, either at an in-person conference or via a virtual course or webinar. We'll detail the patient's demographics, presentation, labs, and any other relevant information in each month's newsletter and then reveal the therapeutic outcome.

Let's dive into August's clinical case, first presented virtually to the audience at CMHC's Spring 2022 Congress in Scottsdale by Katherine R. Tuttle, MD. Here are the details of Dr. Tuttle's patient case: 

• 75-year-old woman with hypertension and type 2 diabetes
• Originally from rural Alabama, moved to the Northwest 40 years ago with the U.S. Air Force
• Hospitalized three times in four months for congestive heart failure
• Medications: furosemide, metoprolol, ACE inhibitor, metformin
• Presents to primary care physician with worsening dyspnea
• BP 124/68 mm Hg, bilateral rales, 2+ edema to mid-calf
• Labs: Serum K 5.2 mEq/L, serum creatinine 1.5 mg/dL/eGFR 34 mL/min/1.73m2 (no race), UACR 800 mg/g, HbAc1 6.8% 
• LVEF 36% by echocardiogram

Based on this presentation, what pillars of therapy can be initiated to optimize the care of Dr. Tuttle's patient?

1. SGLT2 inhibitor with proven benefit (dapagliflozin, canagliflozin, empagliflozin)
2. ARNI (sacubitril/valsartan) in place of ACE inhibitor
3. Add thiazide diuretic
4. a and b

To see which therapeutic option Dr. Tuttle chose for this real patient, watch her case presentation HERE

The American Heart Association (AHA), drawing on data from a 2017 Presidential Advisory and a 2021 Scientific Statement on the mind-heart-body connection, updated its Life's Simple 7™ checklist to include another vital metric: sleep. Read more about the updated metric - now called Life's Essential 8™ - and how it is used to inform a host of cardiometabolic diseases in this CMHC Pulse Blog.

The annual congress from the European Society of Cardiology (ESC) is, first and foremost, a celebration of science designed to challenge and inspire cardiovascular professionals to deliver the best care possible. This August 26-29, CMHC is honored to announce our role as a delegate at the 2022 ESC Congress in Barcelona, Spain! If you'll be at the conference, please stop by the CMHC booth to say hello and claim an UNPRECEDENTED $1000 discount on our Foundations of Cardiometabolic Health Certificate Course. If you haven't yet registered for the ESC Congress, you can REGISTER and browse the ATTENDANCE GUIDE. As an exhibitor, CMHC is excited to enrich face-to face-interactions with industry partners and to welcome visitors from around the world to our booth!